GLENZOCIMAB

UNII:	58D9BCH9O0
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	GLENZOCIMAB
GSRS Full Record:	58D9BCH9O0 i

2101829-58-5
ACT-017
ACT017
GLENZOCIMAB [USAN]
Glenzocimab
Glenzocimab [WHO-DD]
Immunoglobulin Fab G1-kappa, anti-[Homo sapiens GP6 (glycoprotein VI platelet, glycoprotein VI (platelet), GPVI, platelet glycoprotein VI)], humanized monoclonal antibody; gamma1 heavy chain VH-CH1 humanized (1-227) [VH (Homo sapiens IGHV1-46*01 (92.9%) -(IGHD) -IGHJ4*01 (93.3%)) [8.8.13] (1-120) -Homo sapiens IGHG1*01, G1m17 (CH1 K120 (217) (121-218), hinge 1-9 (219-227)) (121-227)], (223-214')-disulfide with kappa light chain humanized (1'-219') [V-KAPPA (Homo sapiens IGKV1-33*01 (80.0%) -IGKJ1*01 (100%)) [11.3.9] (1'-111') -1-mer (112') -Homo sapiens IGKC*01 (100%), Km3 A45.1 (158), V101 (196) (113'-219')]
Immunoglobulin G1, anti-(human platetet glycoprotein VI) Fab fragment (humanized monoclonal ACT017 γ1-chain), disulfide with humanized monoclonal ACT017 κ-chain
glenzocimab [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

GLENZOCIMAB

Synonyms and Mappings

Resources